3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
9
Breast Neoplasms
7
Neoplasms
4
Lymphoma
4
Brain Neoplasms
4
Lymphoma, Non-Hodgkin
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Lymphoma, B-Cell
2
Liver Neoplasms
2
Leukemia
2
Head and Neck Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Hepatocellular
2
Carcinoma in Situ
2
Burkitt Lymphoma
2
Vulvar Neoplasms
1
Vulvar Diseases
1
Vasculitis
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Squamous Cell Carcinoma of Head and Neck
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Philadelphia Chromosome
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Osteomyelitis
1
Neurofibromatosis 1
1
Interventions
Temozolomide
14
Bevacizumab
11
Erlotinib Hydrochloride
5
Radiotherapy
4
Carboplatin
4
Magnetic Resonance Spectroscopy
3
Irinotecan
3
Immunoglobulin G
3
Disulfides
3
temsirolimus
2
poly ICLC
2
palbociclib
2
etoposide phosphate
2
antineoplaston AS 2-1
2
antineoplaston A10
2
Vincristine
2
Sunitinib
2
Sirolimus
2
Everolimus
2
Dasatinib
2
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
2
veliparib
1
varlilumab
1
vandetanib
1
trebananib
1
trametinib
1
terameprocol
1
tandutinib
1
selinexor
1
romidepsin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Oligodendroglioma
×
Magnetic Resonance Imaging
×
Clear all
No trials found.